EV/EBITDA
-1.48
-0.14-10.45%
Fri, 07 Feb 2025 21:52:21 GMT
Summary
- As of February 8, 2025, ENLV EV/EBITDA is -1.48, with a fall of -0.14 (-10.45%) during the most recent trading day.
- Over the past year, ENLV EV/EBITDA has increased by +0.46 (+23.71%).
- ENLV EV/EBITDA is now -122.39% below its all-time high of 6.61.
Performance
ENLV EV/EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
EV/EBITDA Formula
EV/EBITDA = Enterprise Value
TTM EBITDA
Enterprise Value
TTM EBITDA
TTM EBITDA
ENLV EV/EBITDA Trends
| PeriodPeriod | EV/EBITDAEV/EBITDA | Enterprise valueEnterprise value | PricePrice |
|---|---|---|---|
| todaytoday | -10.4% | +10.6% | +9.7% |
| 1 m1 month | +8.1% | -8.0% | -7.4% |
| 3 m3 months | +10.8% | -11.2% | -10.3% |
| 6 m6 months | -24.4% | +7.1% | -2.6% |
| ytdytd | +3.9% | -3.8% | -3.5% |
| 1 y1 year | +23.7% | -51.7% | -55.4% |
| 5 y5 years | +83.7% | -70.1% | -85.4% |
ENLV EV/EBITDA Highs & Lows
| PeriodPeriod | HighHigh | Current vs highvs high | LowLow | Current vs lowvs low | |
|---|---|---|---|---|---|
| 1 m | 1-month | -10.4% | -1.61 | +8.1% | |
| 3 m | 3-month | -1.14 | -29.8% | -1.79 | +17.3% |
| 6 m | 6-month | -1.14 | -29.8% | -2.39 | +38.1% |
| 1 y | 1-year | -0.83 | -78.3% | -3.80 | +61.0% |
| 3 y | 3-year | -0.14 | -957.1% | -5.19 | +71.5% |
| 5 y | 5-year | -0.14 | -957.1% | -39.00 | +96.2% |
| alltime | all time | 6.61 | -122.4% | -53.73 | +97.3% |
Enlivex Therapeutics EV/EBITDA History
| Date | Value |
|---|---|
| 2025 | -1.48(-3.9%) |
| 2024 | -1.54(-25.6%) |
| 2023 | -2.07(+88.2%) |
| 2022 | -1.10(-81.2%) |
| 2021 | -5.84(-52.8%) |
| 2020 | -12.37(+25.6%) |
| Date | Value |
|---|---|
| 2019 | -9.85(-813.8%) |
| 2018 | 1.38(-170.1%) |
| 2017 | -1.97(+207.8%) |
| 2016 | -0.64(-79.3%) |
| 2015 | -3.09(-72.8%) |
| 2014 | -11.36 |
FAQ
- What is Enlivex Therapeutics EV/EBITDA?
- What is the all time high EV/EBITDA for Enlivex Therapeutics?
- What is ENLV EV/EBITDA year-to-date change?
- What is Enlivex Therapeutics EV/EBITDA year-on-year change?
What is Enlivex Therapeutics EV/EBITDA?
The current EV/EBITDA of ENLV is -1.48
What is the all time high EV/EBITDA for Enlivex Therapeutics?
Enlivex Therapeutics all-time high EV/EBITDA is 6.61
What is ENLV EV/EBITDA year-to-date change?
Enlivex Therapeutics EV/EBITDA has changed by +0.06 (+3.90%) since the beginning of the year
What is Enlivex Therapeutics EV/EBITDA year-on-year change?
Over the past year, ENLV EV/EBITDA has changed by +0.46 (+23.71%)